Fortitude Family Office’s Verrica Pharmaceuticals VRCA Stock Holding History

Fortitude Family Office’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$609	Hold	127	–	–	﹤0.01%	2359
2026 Q2	$777	Hold	127	–	–	﹤0.01%	1840
2026 Q1	$672	Sell	127 -481	-79%	-$3.08K	﹤0.01%	1620
2025 Q4	$5.05K	Buy	+608	New	+$3.37K	﹤0.01%	806

Fortitude Family Office's VRCA Position: Q3 2026 in Review

Fortitude Family Office held its Verrica Pharmaceuticals (VRCA) position steady in Q3 2026 at 127 shares worth $609. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

Fortitude Family Office first reported a position in VRCA in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.05K in Q4 2025. 1 fund tracked by Wall St. Rank holds VRCA as of Q3 2026.

Fortitude Family Office held 127 shares of Verrica Pharmaceuticals worth $609 as of Q3 2026.
Fortitude Family Office left its Verrica Pharmaceuticals share count unchanged in Q3 2026.
Verrica Pharmaceuticals made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2359 holding.
Fortitude Family Office first reported a position in Verrica Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
Fortitude Family Office's Verrica Pharmaceuticals position peaked at $5.05K in Q4 2025.
1 fund tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.